oxyphencyclimine
Trade name: daricon
Small moleculeapproved
Oxyphencyclimine is an anticholinergic drug (trade name Daricon) used in treating peptic ulcers. Daricon was discontinued in USA, but still used worldwide. — NCATS
Clinical trial activity
0 trials · 0 clinical orgs · 2 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Timeline
Indications
Approved for
Mechanism of action
- Muscarinic acetylcholine receptor M1ANTAGONIST
CHRM1 antagonist
Role in regulating gastric secretion, M1 likely involved
- Muscarinic acetylcholine receptor M3ANTAGONIST
CHRM3 antagonist
Role in regulating gastric secretion, M3 likely involved
Approval history
- approved—
Chemistry & pharmacology
Loading structure…
SMILES
CN1CCCN=C1COC(=O)C(O)(c1ccccc1)C1CCCCC1- Mol. weight
- 344.46 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Racemic Mixture
- Inorganic
- No
- Polymer
- No
- Delivery
- Oral
- Availability
- Discontinued
Oral
Yes
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL1495 ↗
- WikipediaOxyphencyclimine ↗
- NCATS4V44H1O8XI ↗
- ChEMBLCHEMBL1200891 ↗
Also known as
- daricon
- daricon
- daricon
- daricon
- oxifencicliminum
- oxifencicliminum
- oxiphencyclimine chloride
- oxiphencyclimine chloride
- oxyphencyclimine
- oxyphencyclimine
- oxyphencyclimine
- oxyphencyclimine
- oxyphencyclimine
- oxyphencyclimine
- oxyphencyclimine
- oxyphencyclimine
- oxyphencyclimine
- oxyphencyclimine hcl
- oxyphencyclimine hcl
- oxyphencyclimine hcl
- oxyphencyclimine hydrochloride
- oxyphencyclimine hydrochloride
- oxyphencyclimine hydrochloride
- oxyphencyclimine hydrochloride
- oxyphencyclimine hydrochloride
- oxyphencyclimine, (+-)-isomer
- oxyphencyclimine monohydrochloride
- oxyphencyclimine monohydrochloride
- oxyphencyclimine monohydrochloride
- oxyphencyclimine monohydrochloride
- oxyphencyclimine monohydrochloride
- oxyphencyclimine monohydrochloride
- oxyphencycliminum
- oxyphencycliminum